0001555280-21-000235.txt : 20210521
0001555280-21-000235.hdr.sgml : 20210521
20210521164151
ACCESSION NUMBER: 0001555280-21-000235
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210519
FILED AS OF DATE: 20210521
DATE AS OF CHANGE: 20210521
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lagano Roxanne
CENTRAL INDEX KEY: 0001567878
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35797
FILM NUMBER: 21949696
MAIL ADDRESS:
STREET 1: C/O ZOETIS INC.
STREET 2: 100 CAMPUS DRIVE
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07940
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zoetis Inc.
CENTRAL INDEX KEY: 0001555280
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 460696167
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
BUSINESS PHONE: 973-822-7000
MAIL ADDRESS:
STREET 1: 10 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
4
1
wf-form4_162162968922886.xml
FORM 4
X0306
4
2021-05-19
0
0001555280
Zoetis Inc.
ZTS
0001567878
Lagano Roxanne
C/O ZOETIS INC.
10 SYLVAN WAY
PARSIPPANY
NJ
07054
0
1
0
0
Executive Vice President
Common Stock
2021-05-19
4
M
0
1362
41.83
A
43445
D
Common Stock
2021-05-19
4
M
0
4638
55.02
A
48083
D
Common Stock
2021-05-19
4
S
0
6000
169.05
D
42083
D
Stock Option
2021-05-19
4
M
0
1362
0
D
Common Stock
1362.0
58342
D
Stock Option
2021-05-19
4
M
0
4638
0
D
Common Stock
4638.0
53704
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020.
The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions.
Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.
1,362 options granted February 19, 2016 at an exercise price of $41.83 per option.
Each option vests on the third anniversary of the date of grant.
Each option expires on the tenth anniversary of the date of grant.
17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; and 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option.
4,638 options granted February 14, 2017 at an exercise price of $55.02 per option.
12,844 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; and 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option.
/s/ Brenda Santuccio, as Attorney-in-Fact
2021-05-21